Impact of health insurance and socioeconomic status in the outcome of cancer and cardiac diseases

This publication has 15 references indexed in Scilit:

• Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction
  The American Journal of Cardiology, 2020
• Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration
  Lung Cancer, 2020
• Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
  BMC Cancer, 2019
• Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly
  Current Hematologic Malignancy Reports, 2019
• Impact of socioeconomic status on survival following ST-elevation myocardial infarction in a universal healthcare system
  International Journal of Cardiology, 2019
• Socioeconomic status and cardiovascular disease
  International Journal of Cardiology, 2019
• Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
  Advances in Therapy, 2017
• Socioeconomic disparities in childhood cancer survival in Switzerland
  International Journal of Cancer, 2016
• Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide study
  British Journal of Cancer, 2012
• Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare
  Journal of Cancer Epidemiology, 2012